New hope for hard-to-treat prostate cancer: experimental drug enters human testing
Disease control
Recruiting now
This early-stage study tests a new drug called VIR-5500 in people with advanced prostate cancer that has spread and is no longer controlled by standard therapies. The study has four parts, first testing the drug alone, then in combination with other prostate cancer medicines. The…
Phase: PHASE1 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC